Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in NERV — Minerva Neurosciences, Inc.

CIK 1000275 TORONTO, A6
Back to NERV Full portfolio

Position in NERV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,859
+$6,305 QoQ
Shares Held
1,236
+1243.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 58 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NERV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. NERV ranks #311 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in NERV

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,859 1,236
2026-03-31 $554 92
2025-12-31 $9,004 2,240
2025-09-30 $5,115 2,430
2025-06-30 $89 52
2025-03-31 $258 152
2024-12-31 $3,432 1,545
2024-06-30 $5,834 1,829
2024-03-31 $1,416 549
2023-12-31 $3,038 494
2023-09-30 $9,142 1,325
2023-06-30 $1,992 218
2023-03-31 $281 176
2022-09-30 $10,900 1,181
2021-06-30 $20,905 9,011
2021-03-31 $9,936 3,403
2020-12-31 $4,976 2,127
2020-09-30 $190 60
2020-06-30 $1,107 307
2020-03-31 $752 125